TYKi Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-86031
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Summary for TYKi Antibody
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human TYKi. Peptide sequence: PSCIGQWRKIFDDEPTIIRRAFYSLGNYIVASEIAKESAKSPVIVDRYWH The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for TYKi Antibody
![Western Blot: TYKi Antibody [NBP2-86031]](https://resources.bio-techne.com/images/products/TYKi-Antibody-Western-Blot-NBP2-86031-img0001.jpg "Western Blot: TYKi Antibody [NBP2-86031]")
Western Blot: TYKi Antibody [NBP2-86031]
Western Blot: TYKi Antibody [NBP2-86031] - Host: Rabbit. Target Name: CMPK2. Sample Type: Fetal Liver lysates. Antibody Dilution: 1.0ug/mlApplications for TYKi Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TYKi
Alternate Names
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial, cytidylate kinase 2, EC 2.7.4.14, mitochondrial, mitochondrial UMP-CMP kinase, thymidine monophosphate kinase 2, thymidylate kinase family LPS-inducible member, TMPK2, TYKi, UMP-CMPK2
Gene Symbol
CMPK2
Additional TYKi Products
Product Specific Notices for TYKi Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...